Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • sfranzenburg
    Member
    • Mar 2014
    • 28

    #1

    Library Quantification - Size Adjustment

    Hi,
    when you measure the concentration of your input gDNA or libraries (illumina nextera in my case), do you use the same DNA standards (=kit contents) for both? In my understanding, the standards should have a similar size than the actual sample, which is extremely different between input gDNA and 400pb libraries.
    The protocol from Quantifluor mentions this problem (and recommends self-made standards), the protocols for Qubit or Quant-IT don't. Both use lambda DNA (size ~ 48,5 kb) as standards.

    How do you handle that in your everyday routine?

    best,
    Sören
  • pmiguel
    Senior Member
    • Aug 2008
    • 2328

    #2
    A given number of base pairs of double stranded DNA is going to bind a given amount of fluor. How would the length of the DNA molecules change the result?

    --
    Phillip

    Comment

    • sfranzenburg
      Member
      • Mar 2014
      • 28

      #3
      Well, that was my understanding as well.
      But the fact that the Quantifluor-Manual states that you should use standards of the same size as the sample made me wonder if it is really linear.

      quote from the manual:
      "Even though the Lambda DNA Standard is provided with the QuantiFluor dsDNA System, we recommend preparing a standard curve using dsDNA of a similar size as the dsDNA you wish to quantitate. For example, if you are quantitating genomic DNA, you should prepare a standard curve using a genomic DNA sample of known concentration."

      I just wondered if people actually do that? But if, how do you get a sample of known concentration to calibrate your method that measures your concentration. Chicken-Egg problem...

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Beyond CRISPR/Cas9: Understand, Choose, and Use the Right Genome Editing Tool
        by SEQadmin2



        CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).

        Despite this, “CRISPR helped turn genome editing from a specialized technique into
        ...
        07-31-2026, 11:01 AM
      • SEQadmin2
        Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
        by SEQadmin2


        Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

        The systematic characterization of the human proteome has
        ...
        07-20-2026, 11:48 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Yesterday, 10:35 AM
      0 responses
      9 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-06-2026, 07:41 AM
      0 responses
      27 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 08-03-2026, 10:13 AM
      0 responses
      45 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-31-2026, 02:55 AM
      0 responses
      48 views
      0 reactions
      Last Post SEQadmin2  
      Working...